Translational Medicine-Oncology: Developed the clinical strategy for early development molecules and accountable for clinical trials in early oncology drug development (Phase I), encompassing small molecules, immuno-oncology directed therapies, solid tumors and heme malignancies.

Established and led the clinical team focused on lung, head and neck and esophageal cancers. Active member of the clinical trials program in these areas as well as Phase 1 studies.

Internal Medicine and Oncology